4XC1 Intrinsic Valuation and Fundamental Analysis - Kalvista Pharmaceuticals Inc

K	Kalvista Pharmaceuticals Inc SWB:4XC1	US
N	Nippon Steel Corp DUS:NPS	JP

Intrinsic Value

The intrinsic value for Kalvista Pharmaceuticals Inc (4XC1) under the Base Case is 8.01 EUR. Compared with the current market price of 22.8 EUR, the stock appears Overvalued by 65% .

DCF Value

€2.97

Multiples-Based Value

€13.05

DCF Value

€2.97

Multiples-Based Value

€13.05

Both DCF and multiples point to overvaluation.

Why combine DCF with multiples? What is Intrinsic Value?

4XC1 Intrinsic Value

Overvaluation 65%

Intrinsic Value

Price €22.8

Bear Case

Base Case

Bull Case

Track Buy Zone

20% below Intrinsic Value €6.41

Get notified when the price drops into your buy zone

Current Price €22.8

Intrinsic Value €8.01

Margin of Safety 20% €6.41

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Loading...

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Kalvista Pharmaceuticals Inc.

Explain Valuation